Cystic fibrosis: Myths. mistakes, and dogma

Paediatric Respiratory Reviews

Volumn 15, Issue 1, 2014, Pages 113-116

  Rubin, Bruce K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Dogma; Myths; Treatment

Indexed keywords

CHILD; CYSTIC FIBROSIS; DECISION MAKING; DIAGNOSTIC ERROR; EVIDENCE BASED MEDICINE; HUMAN; MEDICATION ERROR; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PROCEDURES;

CHILD; CYSTIC FIBROSIS; DECISION MAKING; DIAGNOSTIC ERRORS; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; MEDICATION ERRORS;

EID: 84893968422     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.11.004     Document Type: Review

References (43)

1. Oscar Wilde (1892) Lady Windermere's Fan, Act 3.
2. Andersen D.H. Cystic fibrosis of the pancreas and its relation to celiac disease. A clinical and pathologic study. Am J Dis Child 1938, 56:344-399.
3. Rohlfs E.M., Zhou Z., Heim R.A., Nagan N., Rosenblum L.S., Flynn K., Scholl T., Akmaev V.R., Sirko-Osadsa D.A., Allitto B.A., Sugarman E.A. Cystic fibrosis carrier testing in an ethnically diverse US population. Clinical Chemistry 2011, 57:841-848.
4. Monaghan K.G., Bluhm D., Phillips M., Feldman G.L. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals unanticipated frequencies for specific mutations. Genet Med 2004, 6:141-144.
5. Yamashiro Y., Shimizu T., Oguchi S., Shioya T., Nagata S., Ohtsuka Y. The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr 1997, 24:544-547.
6. Kabra S.K., Kabra M., Lodha R., Shastri S. Cystic fibrosis in India. Pediatr Pulmonol 2007, 42:1087-1094.
7. Ashavaid T.F., Raghavan R., Dhairyawan P., Bhawalkar S. Cystic fibrosis in India: a systematic review. J Assoc Physicians India 2012, 60:39-41.
8. Gaskin K.J., Gurwitz D., Durie P., Corey M., Levison H. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982, 100:857-862.
9. Soutter V.L., Kristidis P., Gruca M.A., Gaskin K.J. Chronic undernutrition/growth retardation in cystic fibrosis. Clin Gastroenterol 1986, 15:137-155.
10. Littlewood J.M., MacDonald A. Rationale of modern dietary recommendations in cystic fibrosis. J R Soc Med. 1987, 80(Suppl 15):16-24.
11. FitzSimmons S.C., Burkhart G.A., Borowitz D., Grand R.J., Hammerstrom T., Durie P.R., Lloyd-Still J.D., Lowenfels A.B. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997, 336:1283-1289.
12. Matthews L.W., Doershuk C.F., Spector S. Mist tent therapy of obstructive pulmonary lesion of cystic fibrosis. Pediatrics 1967, 39:176-185.
13. Motoyama E.K., Gibson L.E., Zigas C.J. Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curves. Pediatrics 1972, 50:299-306.
14. Chang N., Levison H., Cunningham K., Crozier D.N., Grosett O. An evaluation of nightly mist tent therapy for patients with cystic fibrosis. Am Rev Resp Dis 1973, 107:672-675.
15. Jakobsson B., Hjelte L., Nyström B. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients. J Hosp Infect 2000, 44:37-41.
16. Lopez-Vidriero M.T., Reid L. Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases. Am Rev Respir Dis. 1978, 117:465-477.
17. King M. Is cystic fibrosis mucus abnormal?. Pediatric Res 1981, 15:120-122.
18. Voynow J.A., Rubin B.K. Mucins, mucus, and sputum. Chest 2009, 135:505-512.
19. Rubin B.K. Mucus, phlegm, and sputum in cystic fibrosis. Respir Care 2009, 54:726-732.
20. Albers G.M., Tomkiewicz R.P., May M.K., Ramirez O.E., Rubin B.K. Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability. J Appl Physiol 1996, 81:2690-2695.
21. Dornase positive studies Fuchs HJ, et al. N Engl J Med. 1994.
22. Rubin B.K. Who will benefit from DNase?. Pediatr Pulmonol 1999, 27:3-4.
23. McShane D., Davies J.C., Wodehouse T., Bush A., Geddes D., Alton E.W. Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect. Eur Respir J 2004, 24:95-100.
24. Regnis J.A., Zeman K.L., Noone P.G., Knowles M.R., Bennett W.D. Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia. Exp Lung Res 2000, 26:149-162.
25. Robinson M., Bye P.T. Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol 2002, 33:293-306.
26. Laube B.L., Sharpless G., Carson K.A., Kelly A., Mogayzel P.J. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis. BMC Pulmonary Med 2011, 11:45.
27. Matsui H., Grubb B.R., Tarran R., Randell S.H., Gatzy J.T., Davis C.W., Boucher R.C. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998, 95:1005-1015.
28. Daviskas E., Rubin B.K. Effect of inhaled dry powder mannitol on mucus and its clearance. Expert Rev Respir Med 2013, 7:65-75.
29. Henke M.O., Renner A., Huber R.M., Seeds M.C., Rubin B.K. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol. 2004, 31:86-91.
30. Henke M.O., John G., Rheineck C., Chillappagari S., Naehrlich L., Rubin B.K. Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun. 2011, 79:3438-3444.
31. Marcos V., Zhou Z., Yildirim A.O., Bohla A., Hector A., Vitkov L., Wiedenbauer E.M., Krautgartner W.D., Stoiber W., Belohradsky B.H., Rieber N., Kormann M., Koller B., Roscher A., Roos D., Griese M., Eickelberg O., Döring G., Mall M.A., Hartl D. CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med. 2010, 16:1018-1023.
32. Rubin B.K., Geiger D.W. Pulmonary function, nutrition, and self-concept in cystic fibrosis summer campers. Chest 1991, 42:456-459.
33. Pegues D.A., Carson L.A., Tablan O.C., FitzSimmons S.C., Roman S.B., Miller J.M., Jarvis W.R. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr. 1994, 124:694-702.
34. Auerbach H.S., Williams M., Kirkpatrick J.A., Colten H.R. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985, 2(8457):686-688.
35. Balfour-Lynn I.M., Lees B., Hall P., Phillips G., Khan M., Flather M., Elborn J.S. CF WISE (Withdrawal of Inhaled Steroids Evaluation) Investigators. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. Am J Resp Crit Care Med 2006, 173:1356-1362.
36. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., Yates J.C., Vestbo J. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007, 356:775-789.
37. Fitzgerald D.A., Hilton J., Jepson B., Smith L. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Pediatrics. 2005, 116:e549-e554.
38. Bishop J.R., Erskine O.J., Middleton P.G. Timing of dornase alpha inhalation does not affect the efficacy of an airway clearance regimen in adults with cystic fibrosis: a randomised crossover trial. J Physiother 2011, 57:223-229.
39. Dentice R., Elkins M. Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev. 2013, 6:CD007923.
40. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med. 2005, 353(5):487-497.
41. Bucks R.S., Hawkins K., Skinner T.C., Horn S., Seddon P., Horne R. Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs. J Pedes Psych 2009, 34:893-902.
42. Zindani G.N., Streetman D.D., Streetman D.S., Nasr S.Z. Adherence to treatment in children and adolescent patients with cystic fibrosis. J Adolesc Health 2006, 38:13-17.
43. Isaacs D., Fitzgerald D. Seven alternatives to evidence based medicine. BMJ. 1999 25, 319:1618.